Elsevier Science Ltd.

SHERPA: Unknown

People

  1. Boelens
    Boelens
  2. Oved
    Oved
  3. Troullioud Lucas
    Troullioud Lucas
  4. Harris
    Harris
  5. Maryamchik
    Maryamchik
  6. Mcavoy
    Mcavoy

Groups

  1. Pediatrics, Department of (5)
  2. Stem Cell Transplantation and Cellular Therapy Service (5)
  3. Tow Center for Developmental Oncology (TCDO) (5)
  4. GME, Pediatrics (2)
  5. Graduate Medical Education (2)
  6. Adult Leukemia (1)
  7. Center for Hematologic Malignancies (1)
  8. Department of Medicine (1)
  9. Department of Pathology and Laboratory Medicine (1)
  10. Hematologic Malignancies, Division of (1)
Search Within
  1. "2023"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Pediatrics, Department of (5)
  2. Stem Cell Transplantation and Cellular Therapy Service (5)
  3. Tow Center for Developmental Oncology (TCDO) (5)
  4. GME, Pediatrics (2)
  5. Graduate Medical Education (2)
  6. Adult Leukemia (1)

More Groups

People
  1. Jaap Jan Boelens (5)
  2. Alexandre Troullioud Lucas (2)
  3. Joseph Oved (2)
  4. Alexander Vallone (1)
  5. Andrew Harris (1)
  6. Devin Mcavoy (1)

More People

Years
  1. 2023 (6)
Publications
  1. Cytotherapy (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comprehensive and collaborative workflow to establish customized endpoints and biomarkers for immunotherapy trials
    Meeting Abstract

    Vidal, E. H.; Mcavoy, D.; Vallone, A.; Thomsen, M.; Maslak, P.; Harris, A.; Oved, J.; Hosszu, K.; Boelens, J. J.
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Real world use of the pediatric disease risk index for allogeneic hematopoietic cell transplantation in patients with acute lymphoblastic leukemia: A multicenter study
    Meeting Abstract

    Lucas, A. T.; Nierkens, S.; de Koning, C.; Dandis, R.; Keerthi, D.; Naik, S.; Prockop, S.; Bhoopalan, S.; Boelens, J. J.; Lindemans, C.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • A machine-learning model that incorporates CD45 surface expression predicts hematopoietic progenitor cell recovery after freeze–thaw
    Journal Article

    Al-Riyami, A. Z.; Maryamchik, E.; Hanna, R. S.; Pashmineh Azar, A. R.; Zheng, X.; Choudhari, S.; Finn, C.; Giacobbe, N.; Machietto, R.; Rieser, R.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; A tri-institutional analysis
    Journal Article

    Troullioud Lucas, A. G.; Lindemans, C. A.; Bhoopalan, S. V.; Dandis, R.; Prockop, S. E.; Naik, S.; Keerthi, D.; de Koning, C.; Sharma, A.; Nierkens, S.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant
    Review

    Garcia-Rosa, M.; Abraham, A.; Bertaina, A.; Bhoopalan, S. V.; Bonfim, C.; Cohen, S.; DeZern, A.; Louis, C.; Oved, J.; Pavel-Dinu, M.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Transplant for non-malignant disorders: An International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering
    Guidelines

    Klein, O. R.; Bonfim, C.; Abraham, A.; Ruggeri, A.; Purtill, D.; Cohen, S.; Wynn, R.; Russell, A.; Sharma, A.; Ciccocioppo, R.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save

    • Elsevier Science Ltd. – authorized name for: